This paper addresses the prevention of long COVID, outlining a research and public health agenda aimed at reducing the burden of post-acute sequelae of SARS-CoV-2 infection.
No primary data are presented; the paper appears to be a commentary or perspective piece, limiting the ability to draw evidence-based conclusions from original research.
